These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11325895)

  • 1. Heparin-induced release of protein-bound solutes during hemodialysis is an in vitro artifact.
    De Smet R; Van Kaer J; Liebich H; Lesaffer G; Verstraete A; Dhondt A; Duym P; Lameire N; Vanholder R
    Clin Chem; 2001 May; 47(5):901-9. PubMed ID: 11325895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extremely low doses of heparin release lipase activity into the plasma and can thereby cause artifactual elevations in the serum-free thyroxine concentration as measured by equilibrium dialysis.
    Jaume JC; Mendel CM; Frost PH; Greenspan FS; Laughton CW
    Thyroid; 1996 Apr; 6(2):79-83. PubMed ID: 8733876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of in vitro lipolysis by tetrahydrolipstatin.
    Krebs M; Stingl H; Nowotny P; Weghuber D; Bischof M; Waldhäusl W; Roden M
    Clin Chem; 2000 Jul; 46(7):950-4. PubMed ID: 10894838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A sensitive HPLC method for the quantification of free and total p-cresol in patients with chronic renal failure.
    De Smet R; David F; Sandra P; Van Kaer J; Lesaffer G; Dhondt A; Lameire N; Vanholder R
    Clin Chim Acta; 1998 Nov; 278(1):1-21. PubMed ID: 9877120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of protamine on heparin-induced increases of lidocaine free fraction.
    Dubé LM; Ho-Ngoc A; Davies RF; Beanlands DS; Mousseau N; McGilveray IJ
    Res Commun Chem Pathol Pharmacol; 1983 Dec; 42(3):401-15. PubMed ID: 6665299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicity of free p-cresol: a prospective and cross-sectional analysis.
    De Smet R; Van Kaer J; Van Vlem B; De Cubber A; Brunet P; Lameire N; Vanholder R
    Clin Chem; 2003 Mar; 49(3):470-8. PubMed ID: 12600960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heat inhibition of in vitro lipolysis and 14C ibuprofen protein binding in plasma from heparinized uraemic subjects.
    Pearce GA; Brown KF
    Life Sci; 1983 Oct; 33(15):1457-66. PubMed ID: 6621250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients.
    Bammens B; Evenepoel P; Keuleers H; Verbeke K; Vanrenterghem Y
    Kidney Int; 2006 Mar; 69(6):1081-7. PubMed ID: 16421516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of effect of heparin on the binding of prazosin and phenytoin to plasma proteins.
    Giacomini KM; Giacomini JC; Blaschke TF
    Biochem Pharmacol; 1980 Dec; 29(24):3337-40. PubMed ID: 7213407
    [No Abstract]   [Full Text] [Related]  

  • 10. Elevated free fatty acid concentrations in lipemic sera reduce protein binding of valproic acid significantly more than phenytoin.
    Dasgupta A; Crossey MJ
    Am J Med Sci; 1997 Feb; 313(2):75-9. PubMed ID: 9030671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Removal of P-cresol sulfate by hemodialysis.
    Martinez AW; Recht NS; Hostetter TH; Meyer TW
    J Am Soc Nephrol; 2005 Nov; 16(11):3430-6. PubMed ID: 16120820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodialysis and cell toxicity in vitro related to plasma triglycerides, post-heparin lipolytic activity and free fatty acids.
    Wessel-Aas T; Blomhoff JP; Wirum E; Nilsen T
    Acta Med Scand; 1984; 216(1):75-83. PubMed ID: 6485883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissociation of authentic and artifactual effect of circulating heparin on drug protein binding.
    Dubé LM; Davies RF; Beanlands DS; Mousseau N; Beaudoin N; Chan B; Ho-Ngoc A; McGilveray IJ
    Biopharm Drug Dispos; 1989; 10(1):55-68. PubMed ID: 2923961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of serum lipase in patients undergoing hemodialysis.
    Shibasaki T; Matsuda H; Ohno I; Gomi H; Nakano H; Misawa T; Abe S; Ishimoto F; Kisugi R; Ikeda K; Machida K; Sakai O
    Am J Nephrol; 1996; 16(4):309-14. PubMed ID: 8739284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The artifactual nature of heparin-induced drug protein-binding alterations.
    Brown JE; Kitchell BB; Bjornsson TD; Shand DG
    Clin Pharmacol Ther; 1981 Nov; 30(5):636-43. PubMed ID: 6794969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in vivo and in vitro studies of phenytoin protein binding and in vitro lipolysis in plasma of pregnant and nonpregnant rats.
    Chou RC; Levy G
    J Pharm Sci; 1984 Aug; 73(8):1121-4. PubMed ID: 6491916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide release in the peripheral blood during hemodialysis.
    Rysz J; Luciak M; Kedziora J; Błaszczyk J; Sibińska E
    Kidney Int; 1997 Jan; 51(1):294-300. PubMed ID: 8995746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenol and p-cresol accumulated in uremic serum measured by HPLC with fluorescence detection.
    Niwa T
    Clin Chem; 1993 Jan; 39(1):108-11. PubMed ID: 8419031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of isohydric hemodialysis on the binding and removal of uremic retention solutes.
    Etinger A; Kumar SR; Ackley W; Soiefer L; Chun J; Singh P; Grossman E; Matalon A; Holzman RS; Meijers B; Lowenstein J
    PLoS One; 2018; 13(2):e0192770. PubMed ID: 29470534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum protein binding of phenytoin and valproic acid in insulin-dependent diabetes mellitus.
    Gatti G; Crema F; Attardo-Parrinello G; Fratino P; Aguzzi F; Perucca E
    Ther Drug Monit; 1987 Dec; 9(4):389-91. PubMed ID: 3122377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.